# Topical Treatment for TMJ Arthralgia

> **NCT05816226** · PHASE3 · RECRUITING · sponsor: **University of the Pacific** · enrollment: 90 (estimated)

## Conditions studied

- TMJ Pain

## Interventions

- **DRUG:** Hydrocortisone 2.5%
- **DRUG:** Diclofenac 1% topical

## Key facts

- **NCT ID:** NCT05816226
- **Lead sponsor:** University of the Pacific
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-01
- **Primary completion:** 2026-01
- **Final completion:** 2026-04
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05816226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05816226, "Topical Treatment for TMJ Arthralgia". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05816226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*